Koyfin Home > Directory > Health Care > Adamas Pharma > Cost of Goods Sold

Adamas Pharma Cost of Goods Sold Chart (ADMS)

Adamas Pharma annual/quarterly Cost of Goods Sold from 2017 to 2020.
  • Adamas Pharma Cost of Goods Sold for the quarter ending June 06, 2020 was $0m a -143.83% decrease of -1m year over year
  • Adamas Pharma Cost of Goods Sold for the last 12 months ending June 06, 2020 was $2m a -5.94% decrease of 0m year over year
  • Adamas Pharma Annual Cost of Goods Sold for 2019 was $2m a 74.36% increase of 2m from 2018
  • Adamas Pharma Annual Cost of Goods Sold for 2018 was $1m a 97.31% increase of 1m from 2017
  • Adamas Pharma Annual Cost of Goods Sold for 2017 was $0m
Other Income Statement Metrics:
  • Adamas Pharma EBITDA for the quarter ending December 12, 2018 was $-25m a -22.88% increase of 6m year over year
  • Adamas Pharma Net Income for the quarter ending December 12, 2018 was $-29m a -21.08% increase of 6m year over year
  • Adamas Pharma Total Revenue for the quarter ending September 09, 2018 was $11m a 94.65% increase of 10m year over year
View Chart On Koyfin

Quarterly ADMS Cost of Goods Sold Data

06/2020$0m
03/2020$1m
12/2019$0m
09/2019$1m
06/2019$1m
03/2019$0m
12/2018$0m
09/2018$0m
06/2018$0m
03/2018$0m

Annual ADMS Cost of Goods Sold Data

2019$2m
2018$1m
2017$0m